Ascent Taps M&A Vets for Board in Strategic Overhaul

SCHAUMBURG, Ill. – April 01, 2026 – Ascent Industries Co. has appointed two highly regarded specialty chemicals executives to its Board of Directors, a decisive move that underscores the company's pivot to an aggressive growth phase following a multi-year strategic overhaul. Carmen J. Giannantonio, a veteran of DuPont's M&A division, and Jeremy F. Rohen, Co-CEO of distribution giant Tilley Distribution, will join the board effective today, April 1, 2026.

The appointments signal a clear intent by the Schaumburg-based company (Nasdaq: ACNT) to leverage specialized expertise in mergers, acquisitions, and high-service distribution as it solidifies its new identity as a pure-play specialty chemicals platform.

A Transformation Complete, A New Chapter Begins

These board changes are not a routine reshuffling but the capstone on a deliberate and profound transformation. Over the past two years, Ascent has systematically divested its legacy industrial assets to focus exclusively on the higher-margin specialty chemicals market. This strategic portfolio realignment included the sale of its Specialty Pipe & Tube assets in late 2023, followed by the divestiture of Bristol Metals in April 2025 and, most critically, the sale of American Stainless Tubing, LLC in June 2025.

Company leadership described the final sale as a "defining moment," officially completing its transition. The goal has been to create a more scalable, high-margin business focused on performance-driven chemical solutions for industries like agriculture, water treatment, and industrial cleaning. With the structural changes now complete, the focus shifts to execution and expansion.

"Over the past two years, we have restructured Ascent into a pure-play specialty chemicals company and significantly strengthened the foundation of the business," said J. Bryan Kitchen, President and Chief Executive Officer. "We are now focused on scaling that foundation, driving consistent execution, disciplined growth, and high-value outcomes for our customers and shareholders."

Heavyweights for a Growth Mandate

The backgrounds of the new directors are directly aligned with this new mandate. Carmen J. Giannantonio brings over four decades of experience in finance and corporate strategy, most notably as Vice President of Mergers & Acquisitions at DuPont de Nemours, Inc. During his tenure, he was instrumental in transformational transactions valued at over $200 billion, playing a central role in major separations, acquisitions, and strategic repositioning. His deep expertise in portfolio shaping and capital allocation is precisely what a company like Ascent needs as it looks to deploy capital from its recent divestitures into new growth opportunities, including potential M&A.

Jeremy F. Rohen provides a complementary skill set crucial for market expansion. As Co-CEO and COO of Tilley Distribution, Inc., he possesses extensive experience in the high-service distribution models that are vital in the specialty chemicals value chain. His background also includes senior strategy and corporate development roles at Axalta Coating Systems and W. R. Grace & Co., giving him a comprehensive view of the industry from both the manufacturing and distribution sides.

Board Chairman Ben Rosenzweig noted the strategic fit, stating, “Carmen and Jeremy bring highly relevant, real-world experience in specialty chemicals, distribution, and portfolio transformation, capabilities that will further strengthen our Board as we support the Company’s next phase of growth.”

Kitchen added that their expertise is critical in environments "where reliability, responsiveness, and technical partnership matter most," and that their track record of creating value through "thoughtful portfolio shaping and disciplined capital deployment" will be instrumental for Ascent's future.

Governance Evolves with Strategy

The board expansion, which grows from five to seven members, is also accompanied by a planned transition. John P. Schauerman, who has served on the board since June 2020 and chairs the Audit Committee, will not stand for re-election. Company filings confirm the decision is amicable and not the result of any disagreement.

Schauerman's tenure was pivotal during the company’s most intense period of transformation, where his oversight was instrumental in strengthening governance and internal controls. His departure marks a symbolic shift in the board's focus—from a period of restructuring and compliance enhancement to one centered on strategic growth and capital deployment. Rosenzweig thanked Schauerman for his "meaningful contributions" and for positioning the company for this next phase.

Navigating a Dynamic Market

The strategic appointments come as Ascent navigates a complex but promising specialty chemicals market. The global market is projected to grow at a compound annual growth rate of around 5%, reaching over $1.3 trillion by 2030, fueled by demand from automotive, construction, and electronics sectors, as well as a growing emphasis on sustainability.

However, the industry also faces headwinds, including supply chain disruptions, rising operational costs, and regulatory hurdles. Ascent’s own financial performance reflects this duality. For the full year 2025, the company reported a 7.3% decrease in net sales to $74.9 million, but its gross profit surged an impressive 61% to $17.2 million. This reflects successful cost management and a focus on higher-margin products, a core tenet of its new strategy.

Despite these operational improvements, the company posted a net loss of $5.6 million for the year, and a challenging fourth quarter led to a significant drop in its stock price. Investors are watching closely to see if the strategic realignment will translate into consistent profitability. Ascent entered 2026 debt-free with $16.1 million in cash and has an active share repurchase program, signaling confidence from management. The addition of Giannantonio and Rohen appears to be a direct move to bolster investor confidence and provide the strategic oversight needed to turn improved gross margins into sustainable net income and shareholder value. Their combined experience in disciplined growth and value creation will be put to the test as Ascent aims to achieve its long-term targets of 30-35% gross margins and a 15% EBITDA margin.